Biological Dynamics Inc (Biological Dynamics) operates as a molecular diagnostics company. It offers a proprietary lab-on-a-chip (LOC) platform, Verita utilizes AC electrokinetics (ACE) technology for the isolation of nanoparticles and macromolecules from biofluids including whole blood, plasma and serum. It also develops lung assays to support treatment response in patients with non-small cell lung cancer. Biological Dynamics utilizes its platform to develop minimally invasive diagnostic assays that detect biomarkers including cell-free DNA, exosomes, exo-proteins, and other cellular particles. The company also utilizes ACE technology to improve the detection, treatment and monitoring of cancers. Biological Dynamics is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biological Dynamics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Biological Dynamics Inc Company Overview
- Biological Dynamics Inc Company Snapshot
- Biological Dynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biological Dynamics Inc - Pipeline Analysis Overview
- Biological Dynamics Inc - Key Facts
- Biological Dynamics Inc - Major Products and Services
- Biological Dynamics Inc Pipeline Products by Development Stage
- Biological Dynamics Inc Ongoing Clinical Trials by Trial Status
- Biological Dynamics Inc Pipeline Products Overview
- ExoVerita System
- ExoVerita System Product Overview
- ExoVerita System Clinical Trial
- ExoVita Pancreas Assay
- ExoVita Pancreas Assay Product Overview
- ExoVita Pancreas Assay Clinical Trial
- NanoVerita System
- NanoVerita System Product Overview
- OmniVerita System
- OmniVerita System Product Overview
- OncoState Lung Assay
- OncoState Lung Assay Product Overview
- Solid Tumor Diagnostic Test
- Solid Tumor Diagnostic Test Product Overview
- Verita - Tuberculosis Assay
- Verita - Tuberculosis Assay Product Overview
- Biological Dynamics Inc - Key Competitors
- Biological Dynamics Inc - Key Employees
- Biological Dynamics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Biological Dynamics Inc, Recent Developments
- Apr 02, 2024: Biological Dynamics Announces Expanding Adoption of ExoVerita Pro Under Early Access Program
- Dec 05, 2023: Leading Academic Medical Centers Join Biological Dynamics’ ExoLuminate Study, Expanding Enrollment for Early Pancreatic Cancer Detection
- Oct 19, 2023: New Study Using Biological Dynamics’ Exoverita Platform Validates Exosome Detection of Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC)
- Oct 05, 2023: Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts
- May 26, 2023: Biological Dynamics case report published in frontiers in oncology demonstrates advancement in the detection of early-stage pancreatic lesions
- Mar 01, 2023: Biological Dynamics and Oregon Health & Science University collaborate on early-stage pancreatic cancer detection study
- Feb 08, 2023: Biological Dynamics launches ExoVita pancreas and enrolls patients in ExoLuminate clinical trial
- Jan 31, 2023: Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research
- Jan 17, 2023: Biological Dynamics Appoints Industry Veteran Peter Wulff as Chief Financial Officer
- Dec 07, 2022: Biological Dynamics to participate at 2022 PRECEDE Biomarker Summit
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Biological Dynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biological Dynamics Inc Pipeline Products by Equipment Type
- Biological Dynamics Inc Pipeline Products by Indication
- Biological Dynamics Inc Ongoing Clinical Trials by Trial Status
- Biological Dynamics Inc, Key Facts
- Biological Dynamics Inc, Major Products and Services
- Biological Dynamics Inc Number of Pipeline Products by Development Stage
- Biological Dynamics Inc Pipeline Products Summary by Development Stage
- Biological Dynamics Inc Ongoing Clinical Trials by Trial Status
- Biological Dynamics Inc Ongoing Clinical Trials Summary
- ExoVerita System - Product Status
- ExoVerita System - Product Description
- ExoVerita System - A Retrospective Study to Validate the ExoVerita Platform
- ExoVita Pancreas Assay - Product Status
- ExoVita Pancreas Assay - Product Description
- ExoVita Pancreas Assay - Exoluminate Study: Observational Registry Study to Assess Exo-PDAC Assay Performance for Detection of Pancreatic Adenocarcinoma (PDAC) in High-Risk or Clinically Suspicious Patients
- NanoVerita System - Product Status
- NanoVerita System - Product Description
- OmniVerita System - Product Status
- OmniVerita System - Product Description
- OncoState Lung Assay - Product Status
- OncoState Lung Assay - Product Description
- Solid Tumor Diagnostic Test - Product Status
- Solid Tumor Diagnostic Test - Product Description
- Verita - Tuberculosis Assay - Product Status
- Verita - Tuberculosis Assay - Product Description
- Biological Dynamics Inc, Key Employees
- Glossary
- Biological Dynamics Inc Pipeline Products by Equipment Type
- Biological Dynamics Inc Pipeline Products by Development Stage
- Biological Dynamics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Caerus Molecular Diagnostics, Inc.
- Alexeter Technologies LLC
- Roche Molecular Systems Inc
- Biocept Inc
- Alexeter Technologies LLC
- Caerus Molecular Diagnostics, Inc.
- Roche Molecular Systems Inc
- Biocept Inc
